QPPV.COM KNOWLEDGE ASSESSMENT

GVP Module IX: Signal Detection, Validation and Confirmation

Test your understanding of the concepts covered by GVP Module IX: Signal Detection, Validation and Confirmation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why should signal management examine new aspects of known risks?

Known risks are excluded from all further monitoring A known event may show a materially different severity, latency, population, dose relationship or interaction pattern Only new event terms can have regulatory significance New aspects of known risks are relevant only to clinical trials

Question 2 of 10 What is the principal purpose of signal detection in an EU pharmacovigilance system?

To identify observations that may warrant further examination To establish a causal relationship between a medicine and an event To determine whether regulatory action is legally mandatory To confirm that the product's benefit-risk balance is unfavourable

Question 3 of 10 Which documentation would best support reconstruction of a detection-to-validation decision during an inspection?

Only the final database status The original alert, information reviewed, clinical assessment, rationale, decision and next action Only the name of the person who entered the alert A list of all reports in the safety database without assessment notes

Question 4 of 10 Why is the number of individual case reports an incomplete measure of evidential strength?

Reports are never useful unless they are supported by an epidemiological study A high number of poorly characterised cases may be less informative than a few detailed, distinctive cases Case reports can only be used for known adverse reactions A low case count always indicates that the event is clinically unimportant

Question 5 of 10 What is meant by assessing the totality of evidence in a signal investigation?

Selecting the single evidence source with the strongest numerical result Giving equal weight to all available evidence regardless of quality Integrating different evidence sources while considering their relevance, strengths and limitations Discarding clinical evidence when epidemiological results are available

Question 6 of 10 What is the correct relationship between validation and prioritisation?

Prioritisation determines whether an observation qualifies for validation Validation establishes whether further investigation is justified; prioritisation then determines urgency and resources Prioritisation replaces clinical review during validation Both are identical decisions and should use one combined threshold

Question 7 of 10 Which outcome is legitimate for a validated signal when evidence remains insufficient?

Automatic confirmation because the signal was validated Permanent closure without further governance Retention of uncertainty with defined monitoring or evidence-generation activities Deletion of the original observation to avoid future confusion

Question 8 of 10 What is the appropriate interpretation of improvement after treatment withdrawal in an individual case?

It proves causality in every circumstance It can support a causal hypothesis but must be interpreted against spontaneous recovery and other interventions It has no relevance to signal assessment It is stronger evidence than recurrence after re-exposure in all circumstances

Question 9 of 10 Which metric would be more meaningful for evaluating signal-management process performance than the number of validated signals?

The total number of alerts generated, without regard to product exposure The number of staff employed in pharmacovigilance Timeliness of review, overdue assessments, escalation and completion of resulting actions The proportion of signals that lead to regulatory action

Question 10 of 10 Which factor could create an apparent disproportionality that is not caused by the medicinal product itself?

Indication-related risk or co-medication The existence of a formal signal owner A documented validation rationale A consistent clinical phenotype across independent datasets

QPPV.com

GVP Module IX: Signal Detection, Validation and Confirmation

Cookie Settings